Anfossi N - Search Results

1

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.

Romagné F, André P, Spee P, Zahn S, Anfossi N, Gauthier L, Capanni M, Ruggeri L, Benson DM Jr, Blaser BW, Della Chiesa M, Moretta A, Vivier E, Caligiuri MA, Velardi A, Wagtmann N. Romagné F, et al. Among authors: anfossi n. Blood. 2009 Sep 24;114(13):2667-77. doi: 10.1182/blood-2009-02-206532. Epub 2009 Jun 24. Blood. 2009. PMID: 19553639 Free PMC article.

2

Clinical analysis of human natural killer cells.

André P, Anfossi N. André P, et al. Among authors: anfossi n. Methods Mol Biol. 2008;415:291-300. doi: 10.1007/978-1-59745-570-1_17. Methods Mol Biol. 2008. PMID: 18370161

3

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.

André P, Castriconi R, Espéli M, Anfossi N, Juarez T, Hue S, Conway H, Romagné F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, Paul P. André P, et al. Among authors: anfossi n. Eur J Immunol. 2004 Apr;34(4):961-71. doi: 10.1002/eji.200324705. Eur J Immunol. 2004. PMID: 15048706 Free article.

4

Human NK cell education by inhibitory receptors for MHC class I.

Anfossi N, André P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagné F, Ugolini S, Vivier E. Anfossi N, et al. Immunity. 2006 Aug;25(2):331-42. doi: 10.1016/j.immuni.2006.06.013. Epub 2006 Aug 10. Immunity. 2006. PMID: 16901727 Free article.

5

Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.

Cognet C, Farnarier C, Gauthier L, Frassati C, André P, Magérus-Chatinet A, Anfossi N, Rieux-Laucat F, Vivier E, Schleinitz N. Cognet C, et al. Among authors: anfossi n. Clin Immunol. 2010 Apr;135(1):26-32. doi: 10.1016/j.clim.2009.12.009. Epub 2010 Jan 25. Clin Immunol. 2010. PMID: 20093094

6

Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future.

Vivier E, Anfossi N. Vivier E, et al. Among authors: anfossi n. Nat Rev Immunol. 2004 Mar;4(3):190-8. doi: 10.1038/nri1306. Nat Rev Immunol. 2004. PMID: 15039756 Review. No abstract available.

7

Biology of T memory type 1 cells.

Anfossi N, Pascal V, Vivier E, Ugolini S. Anfossi N, et al. Immunol Rev. 2001 Jun;181:269-78. doi: 10.1034/j.1600-065x.2001.1810123.x. Immunol Rev. 2001. PMID: 11513148 Review.

8

Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells.

Ugolini S, Arpin C, Anfossi N, Walzer T, Cambiaggi A, Förster R, Lipp M, Toes RE, Melief CJ, Marvel J, Vivier E. Ugolini S, et al. Among authors: anfossi n. Nat Immunol. 2001 May;2(5):430-5. doi: 10.1038/87740. Nat Immunol. 2001. PMID: 11323697

9

Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells.

Anfossi N, Doisne JM, Peyrat MA, Ugolini S, Bonnaud O, Bossy D, Pitard V, Merville P, Moreau JF, Delfraissy JF, Dechanet-Merville J, Bonneville M, Venet A, Vivier E. Anfossi N, et al. J Immunol. 2004 Dec 15;173(12):7223-9. doi: 10.4049/jimmunol.173.12.7223. J Immunol. 2004. PMID: 15585844

10

Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line.

Anfossi N, Lucas M, Diefenbach A, Bühring HJ, Raulet D, Tomasello E, Vivier E. Anfossi N, et al. Eur J Immunol. 2003 Dec;33(12):3514-22. doi: 10.1002/eji.200324573. Eur J Immunol. 2003. PMID: 14635062 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters